Palisade Bio Welcomes Biopharmaceutical Industry Veterans Robert Baltera and Jordan Zwick to its Board of Directors
Summary
Palisade Bio added Robert Baltera and Jordan Zwick to its Board of Directors. The company says both directors bring experience in biotechnology leadership, strategic transactions, capital markets, and corporate governance. Palisade Bio is advancing PALI-2108 toward Phase 2 development and says the new board expertise will support that growth. The announcement highlights the company’s clinical progress, financing history, and long-term value creation plans.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected